Pyridinoylpiperidines as 5-HT1F agonists
US8748459B2 · kind B2 · utility
5Cited by
17References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2012 |
| Grant date | Jun 10, 2014 |
| Priority date | — |
| Expiry date | Feb 1, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula I:or pharmaceutically acceptable acid addition salts thereof, where; The compounds of the present invention are useful for activating 5-HTlF receptors, inhibiting neuronal protein extravasation, and for the treatment or prevention of migraine in a mammal. The present invention also relates to a process for the synthesis of intermediates in the synthesis of compounds of Formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.